Search alternatives:
small decrease » small increased (Expand Search)
anc decrease » nn decrease (Expand Search), awd decreased (Expand Search), ash decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ anc » _ any (Expand Search), _ auc (Expand Search)
small decrease » small increased (Expand Search)
anc decrease » nn decrease (Expand Search), awd decreased (Expand Search), ash decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ anc » _ any (Expand Search), _ auc (Expand Search)
-
1
-
2
-
3
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Comparison of ANC between 2017 and 2022.
Published 2025“…</p><p>Results</p><p>In 2017--2018, 48% of women attended four or more visits, which decreased to 41% in 2022. ANC attendance for eight or more visits declined from 12% to 5%, and approximately 8% of women received no ANC in both periods. …”
-
15
-
16
-
17
-
18
-
19
-
20